BioSpace News Archive

Oxford Biomedica plc, a leading cell and gene therapy group, announces its preliminary results for the year ended 31 December 2021.

A just-published research study confirms the long-term safety of Dolcas Biotech, LLC’s CURCUGEN® curcumin formulation.

Bausch Health Companies Inc. announced that, in connection with its previously announced intention to separate its eye health business, its wholly owned subsidiary, Bausch + Lomb Corporation, is seeking to enter into a new credit agreement, which is expected to include a $2.5 billion term B loan facility and $500 million revolving facility.

Mirion Technologies, Inc. (NYSE: MIR) (“Mirion”) (“Company”) announced today that it will release its financial results for the first quarter of 2022 on Wednesday, May 4, 2022.

AlloVir today announced that the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy designation to its lead investigational multi-virus-specific T cell therapy, posoleucel.

SCYNEXIS, Inc. announced the presentation of interim data from its ongoing Phase 3 FURI and CARES studies, as well as multiple posters regarding studies of ibrexafungerp at the 32nd European Congress of Clinical Microbiology and Infectious Diseases being held in Lisbon, Portugal, April 23-26, 2022.

Albany NY, United States: According to the report, the global prefilled syringes market was valued at US$ 5.6 Bn in 2020 and is projected to expand at a CAGR of 13.9% from 2021 to 2028.

Enochian BioSciences today is announcing the appointment of Dr. François Binette, Ph.D. as Executive Vice President for Research and Development.

MicroVention, Inc. announced the successful completion of its first enrollment in a multi-center, prospective EU observational study called STRAIT.

Biond Biologics Ltd. today announced that Tehila Ben Moshe will be presenting therapeutics targeting ILTs (also known as LILRBs) at the LILRB/ILT Virtual Symposium titled: “Deep Dive into “Myeloid Checkpoint” Therapeutics in Cancer”, hosted by Raymond James on April 26, 2022.